## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients
Dilemma of clinically node-negative head and neck melanoma: Outcome of “watch and wait” policy, elective lymph node dissection, and sentinel node biopsy—A systematic review
✍ Scribed by Pieter J. Tanis; Omgo E. Nieweg; Michiel W. M. van den Brekel; Alfons J. M. Balm
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 128 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
The management of patients with clinically node‐negative melanoma of the head and neck remains controversial.
Methods
This is a systematic review of management strategies for stage I head and neck melanoma.
Results
Subgroup analysis of 1 randomized controlled trial (RCT) and most available cohort studies do not reveal a significant impact of elective neck dissection on survival. For 1.2‐ to 3.5‐mm‐thick melanoma at all anatomical sites, 1 RCT does not show an overall significant melanoma‐specific survival benefit of sentinel node biopsy, but subgroup analysis suggests a survival benefit for lymph node–positive patients, confirming findings from 3 retrospective series. Sentinel node biopsy in the head and neck region can be technically demanding, with lower identification rates and higher false‐negative rates.
Conclusion
There is no conclusive survival advantage of either elective neck dissection or sentinel node biopsy in patients with clinically node‐negative head and neck melanoma of intermediate thickness. © 2008 Wiley Periodicals, Inc. Head Neck, 2008
📜 SIMILAR VOLUMES
## BACKGROUND. Sentinel lymph node (SLN) biopsy originally was described as a means of identifying lymph node metastases in malignant melanoma and breast carcinoma. The use of SLN biopsy in patients with oral and oropharyngeal squamous cell carcinoma and clinically N0 necks was investigated to det
## Abstract ## Background Critical evaluation of outcome of primary parotid carcinoma treatment is limited by pathologic diversity and low incidence numbers. Scientific evidence for the optimal management of the N0‐neck is scarce and was, therefore, investigated in a systematic literature review.
## Abstract ## Background Axillary recurrence after negative sentinel lymph node biopsy (SLNB) in patients with invasive breast carcinoma remains a concern. Previous investigations to identify prognostic factors for axillary recurrence identified that a disproportionate number of patients with an